EU-Startups
Finnish startup Avenue Biosciences secures €4.8 million to help drugmakers manufacture proteins more reliably
Helsinki-based Avenue Biosciences, a protein engineering technology company, today announced a Seed extension of €4.8 million ($5.7 million) to scale a high-throughput protein engineering tech that […]
